Starting HRT After 60: What the Timing Hypothesis Really Says

For twenty years, the story of hormone replacement therapy was a warning. A large trial in the early 2000s linked it to raised risks, and a generation of women, and their doctors, backed away. Then the science was re-examined, and a more careful picture emerged: much depends on when you start. Now the pendulum has swung again, and social media is full of confident voices telling women in their sixties it is never too late. The truth sits between the old fear and the new hype. This guide explains the timing hypothesis, what it means for starting hormone therapy after 60, and how to think about the decision honestly.

In short

• The old blanket scare came from a trial that studied older women starting HRT years after menopause. Re-analysis showed the risk picture is very different for women who start around the time of menopause.
• The timing hypothesis is the result: HRT started under 60, or within about 10 years of menopause, has the most favourable balance of benefit to risk.
• Starting after 60 or more than a decade past menopause is not automatically forbidden, but the risk-benefit balance shifts, so it is an individual decision, not a default yes.
• How you take it matters. Non-oral routes such as skin patches or gels carry a different, often lower, risk profile for some problems than tablets.
• The strongest case is treating genuine symptoms that harm quality of life. Using HRT purely to prevent future disease in a woman past 60 is a weaker, more contested reason.

Why were women scared off HRT in the first place?

Because a major trial reported raised risks, but it largely studied older women starting therapy long after menopause, and that nuance got lost. When the headline results landed, the message received by the public and many doctors was simple: HRT is dangerous. Prescriptions fell sharply, and a lot of women endured severe symptoms rather than risk it.

The detail that mattered took years to surface. The average participant was well past menopause when she started, older than the typical woman seeking help for hot flushes. Applying findings from that group to a 51-year-old starting HRT for symptoms was comparing two different situations. Later reanalyses, and reviews such as one in the British Columbia Medical Journal, made clear that the risks and benefits depend heavily on age and time since menopause. The scare was not invented, but it was over-generalised, and a generation paid for the confusion with untreated symptoms.

What is the timing hypothesis?

The idea that HRT is safest and most beneficial when started around menopause, and that the balance tips less favourably the later you begin. The reasoning centres on the state of the blood vessels. Started early, when arteries are still relatively healthy, oestrogen appears to have a neutral or even helpful effect. Started many years later, when age has already changed the vessels, the same hormone can interact with that older tissue differently.

In practice, this is why guidance converged on a window: beginning HRT under 60, or within roughly ten years of the last period, offers the most favourable risk-benefit ratio for most women. It is not a magic cutoff where safety vanishes at the stroke of midnight on a birthday. It is a gradient. The further past menopause a woman is when she starts, the more the calculation shifts, and the more the decision needs to weigh her individual health rather than follow a blanket rule.

So is it too late to start after 60?

Not automatically, but it is a genuinely individual decision rather than a routine one, and the reason for starting matters. For a healthy woman past 60 with ongoing, quality-of-life-wrecking symptoms, HRT can still be appropriate when the benefits are judged to outweigh the risks and the decision is revisited regularly. The online voices insisting "it is never too late" are not simply wrong; they are pushing back against the years of blanket refusal. But they can overshoot into a different oversimplification.

The honest position is that after 60 the starting bar is higher and the discussion more careful. Existing cardiovascular risk, personal and family history, and the severity of symptoms all weigh in, and the choice of preparation and route becomes more important. This is precisely the kind of decision that should be made with a clinician who can look at the whole picture, not settled by a confident influencer or by a fear left over from 2002. Both extremes fail the individual woman in front of them.

Does the type and route of HRT matter?

Yes, considerably. How the hormone is delivered changes parts of the risk profile, and that becomes more relevant with age. Oestrogen taken as a tablet is processed through the liver in a way that patches, gels and sprays applied to the skin are not. For some risks, that difference means a non-oral route can carry a more favourable profile, which is one reason clinicians often prefer transdermal options for women who start later or have particular risk factors.

There is also the question of what the therapy is meant to achieve. Using HRT to relieve real symptoms, hot flushes, night sweats, and the associated sleep and mood disruption, is its strongest, best-supported use, and those symptoms can persist well past 60. Using it as a general preventive against future disease in an older woman is a weaker and more contested rationale, with the bone-health picture, studied in cohorts such as a British birth cohort followed to age 60-64, being one of the more nuanced areas. Matching the preparation, the route and the goal to the individual is the whole substance of a good decision.

When to see a doctor

See a doctor to weigh HRT properly rather than deciding from headlines or social media, because the right answer genuinely depends on your age, your time since menopause, your health history and your symptoms. Raise any personal or family history of blood clots, stroke, heart disease or hormone-sensitive cancers, since these shape both whether to start and which preparation to use. And treat HRT as a decision to review over time, not a one-off, with the balance of benefit and risk reconsidered as you get older.

This article is educational and does not replace advice from a doctor or pharmacist who knows your health history.